Ayna joins Antag with extensive experience in obesity and clinical pharmacology. She most recently served as Senior Principal ...

REC-4881 is an orally bioavailable, non-ATP-competitive allosteric small molecule MEK 1/2 inhibitor. The platform analyzed cellular models of APC gene loss-the root cause of FAP-to identify compounds ...

Oral hormone therapy may benefit heart health in menopausal women. A new analysis of data from the Women's Health Initiative found that estrogen-based oral hormone therapy had a long-term beneficial ...

Sylvie Grégoire, Chair of Abivax Board of Directors, commented: “We are delighted to welcome Dominik to the Board at such a pivotal moment for Abivax. His extensive background in global medical ...

A proof-of-concept study will test VAS-101, a topical gel using the turmeric extract curcumin, in sickle cell disease (SCD) ...

Key players like Bayer AG and Fusion Pharmaceuticals are driving innovation in radioligand and alpha-particle therapies, addressing crucial market challenges such as radioisotope supply chain ...

Gain valuable insights into novel therapies, ongoing clinical trials, and future innovations shaping the treatment of ...

Neuroscientists have developed a new treatment approach for a language disorder that combines traditional speech therapy with noninvasive electrical stimulation of the brain. Brain stimulation helped ...

Clinical trials improve care and access to novel treatments for advanced gastrointestinal cancers, says Dr. Michael Pishvaian ...

Multiple pharmaceutical agents in clinical trials promise to offer patients eye drops for the management of presbyopia.

Trials are used to test potential medicines, treatments or procedures. The National Institutes for Health define a clinical ...

Scale-up is a common problem encountered in all forms of development across industries, and oral solid dose manufacturing ...